Dose-PlanNet is a physics-guided 3D deep learning model that predicts radiotherapy dose distributions for prostate cancer, aiming to automate complex treatment planning. In a prospective trial, the model achieved comparable target coverage while slightly reducing target homogeneity, yet it significantly improved high-dose organ‑at‑risk sparing. Automated plans met clinical acceptance criteria in most cases across both moderate hypofraction and stereotactic body radiation therapy arms.
The paper presents a generative AI model that predicts 3‑D radiation dose distributions based solely on user‑defined preference settings, allowing planners to balance trade‑offs between organs‑at‑risk and target volumes. This approach offers greater flexibility and personalization compared to traditional deep‑learning models that rely on institutional reference plans. The authors report that their method can outperform the Varian RapidPlan model in adaptability and plan quality in certain scenarios, and it is designed for easy integration with clinical treatment planning systems.
By Riqiang Gao, Simon Arberet, Martin Kraus, Han Liu, Wilko FAR Verbakel, Dorin Comaniciu, Florin-Cristian Ghesu, Ali Kamen
arXiv:2603. 09448v2 Announce Type: replace-cross Abstract: Delineating the clinical target volume (CTV) in radiotherapy involves complex margins constrained by tumor location and anatomical barriers.
By Yoon Jo Kim, Wonyoung Cho, Jongmin Lee, Han Joo Chae, Hyunki Park, Sang Hoon Seo, Jae Myung Noh, Kyungmi Yang, Dongryul Oh, Jin Sung Kim
arXiv:2606. 09898v1 Announce Type: new Abstract: Cancer treatment planning requires decisions across multiple clinical dimensions at once.
By Sujoy Banik, Sayantan Chakraborty, Boishakhi Das Toma, Zainab Ghafoor, Ushashi Bhattacharjee, Koushik Howlader, Tirtho Roy
The paper introduces a Mixture of Multicenter Experts (MoME) framework that leverages diverse clinical strategies to reduce bias in medical AI without sharing data across institutions. MoME integrates specialized expertise from multiple centers, improving generalizability and adaptability of a multimodal target volume delineation model for prostate cancer radiotherapy. The model, trained with few-shot imaging and clinical notes, outperformed baselines, especially in high inter‑center variability or limited data scenarios, and allows local customization without cross‑institutional data exchange.
By Yujin Oh, Sangjoon Park, Xiang Li, Pengfei Jin, Yi Wang, Jonathan Paly, Jason Efstathiou, Annie Chan, Jun Won Kim, Hwa Kyung Byun, Ik Jae Lee, Jaeho Cho, Chan Woo Wee, Peng Shu, Peilong Wang, Caiwen Jiang, Nathan Yu, Jason Holmes, Jong Chul Ye, Quanzheng Li, Wei Liu, Woong Sub Koom, Jin Sung Kim, Kyungsang Kim
arXiv:2606. 09898v2 Announce Type: replace Abstract: Cancer treatment involves decisions across multiple clinical outcomes, yet pathway-informed deep learning models are typically evaluated in isolation, making their relative benefits unclear.
By Sujoy Banik, Sayantan Chakraborty, Boishakhi Das Toma, Zainab Ghafoor, Ushashi Bhattacharjee, Koushik Howlader, Tirtho Roy